Zdrowie i gospodarka · 29/01/1996

FDA Cancels January 1996 Meeting of Oversight Committee for Refusal to File Practices

The Food and Drug Administration (FDA) has cancelled a meeting scheduled for January 1996 of its oversight committee, which reviews the FDA's refusal to file practices on product license applications and establishment applications, due to lack of actions taken by the Center for Biologics Evaluation and Research (CBER) in the previous quarter.